DAVID BATES to Vascular Endothelial Growth Factor A
This is a "connection" page, showing publications DAVID BATES has written about Vascular Endothelial Growth Factor A.
Connection Strength
2.053
-
The splicing factor kinase SRPK1 is a therapeutic target for peripheral vascular disease. Am J Physiol Heart Circ Physiol. 2025 Aug 01; 329(2):H490-H504.
Score: 0.774
-
Altered ratios of pro- and anti-angiogenic VEGF-A variants and pericyte expression of DLL4 disrupt vascular maturation in infantile haemangioma. J Pathol. 2016 06; 239(2):139-51.
Score: 0.413
-
Alternative splicing of TIA-1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance. Mol Oncol. 2015 Jan; 9(1):167-78.
Score: 0.365
-
Blocking endothelial apoptosis revascularizes the retina in a model of ischemic retinopathy. J Clin Invest. 2020 08 03; 130(8):4235-4251.
Score: 0.138
-
The mutant p53-ID4 complex controls VEGFA isoforms by recruiting lncRNA MALAT1. EMBO Rep. 2017 08; 18(8):1331-1351.
Score: 0.111
-
An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease. Nat Med. 2014 Dec; 20(12):1464-71.
Score: 0.092
-
Antiangiogenic actions of vascular endothelial growth factor-A165b, an inhibitory isoform of vascular endothelial growth factor-A, in human obesity. Circulation. 2014 Sep 23; 130(13):1072-80.
Score: 0.091
-
Single-cell transcriptomics identifies aberrant glomerular angiogenic signalling in the early stages of WT1 kidney disease. J Pathol. 2024 10; 264(2):212-227.
Score: 0.046
-
IL-4 regulates specific Arg-1(+) macrophage sFlt-1-mediated inhibition of angiogenesis. Am J Pathol. 2015 Aug; 185(8):2324-35.
Score: 0.024